Radiometer, headquartered in Copenhagen, Denmark, is a leading manufacturer of blood gas analyzers with an annual revenue of approximately DKK 1.8 billion ($300m). First-year Danaher EPS accretion is expected to be $0.12 to $0.14.
"We believe Radiometer is one of the premier companies within the medical technology sector and consider Radiometer a strong foundation for expanding into this attractive market. We intend to build upon Radiometer through both organic growth and strategic acquisitions," says Danaher President and CEO, Mr. H. Lawrence Culp, Jr.
Mr. Culp continues, "We have viewed medical technology as an attractive and complementary expansion opportunity for a number of years. In addition, we have for some time been interested in growing our European presence. Radiometer provides a unique opportunity to achieve both these objectives, and we are looking forward to working with the associates and management to further build on the strong position held by the company.
Danaher will hold a brief conference call today at 8:30 a.m. Eastern Time to discuss the agreement. The dial-in number is 706-643-0434, reference Danaher. A replay will be available by dialing 706-645-9291, ID Code 4479873. The replay will be available through Monday, December 15. In addition, the call will be webcast and archived on Danaher's site for two weeks.
Danaher Corporation is a leading manufacturer of Process/Environmental Controls and Tools and Components. (www.danaher.com)
Statements in this release that are not strictly historical may be "forward-looking" statements, which involve risks and uncertainties. These include risks and uncertainties relating to customer and supplier relationships and prices, competition, market demand, litigation and other contingent liabilities, the integration and operation of acquired businesses, and economic, political, governmental and technological factors affecting the Company's operations, markets, products, services and prices, among others, as set forth in the Company's SEC filings.
SOURCE: Danaher Corporation
CONTACT: Andy Wilson, VP Investor Relations of Danaher Corporation,
+1-212-201-2700, ext. 4402 (until 12:00 p.m.), or +1-202-828-0850
Web site: http://www.danaher.com/